Wire · opportunities
Wandercraft acquires exoskeleton rival Ekso Bionics
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 6 October 2026 · Fusion42 review
Wandercraft has acquired U.S.-based exoskeleton maker Ekso Bionics to create a global robotic mobility company, combining their complementary commercial footprints and technology offerings. Both companies’ devices have FDA and CE approvals and are used worldwide in rehabilitation centers for patients with neurological impairments.
This Wire brief sits within Fusion42's coverage of Healthcare.
◆ ◆ The Wire takeaway
You should map your go-to-market to target combined clinical relationships and reimbursement channels across the US and EMEA as this union expands inside access. Your tech and commercial strategy needs to adapt quickly to serve a broader, global neurorehabilitation market before competitors do.
◆ Coverage
1 source · 5 Oct 2026
◆ Related on Wire
◆ Topics